Tag Archives: Clinical Stage

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value

Clinical-stage cannabinoid-based drug developer Zynerba Pharmaceuticals (NASDAQ:ZYNE) had been one of the strongest-performing pot stocks over the trailing year prior to the start of this past week.


Top